Literature DB >> 23821456

MCM3 protein expression in follicular and classical variants of papillary thyroid carcinoma.

Yusuf Ziya Igci1, Suna Erkilic, Mehri Igci, Ahmet Arslan.   

Abstract

Minichromosome maintenance (MCM) proteins are needed as licensors in the DNA replication of eukaryotic cells and transcriptional control of MCM genes has critical role in the regulation of MCM functions. Different MCM protein family members are proposed as diagnostic or prognostic markers in various cancers due to their increased proliferative potential. Among MCM family members, minichromosome maintenance protein 3 (MCM3) expressions in both mRNA and protein levels were shown to be associated with papillary thyroid carcinoma (PTC). But, the usability of MCM3 in some histological variants of PTC might be controversial due to tissue specific molecular heterogeneities. In follicular variant of papillary thyroid carcinoma (FVPTC), a number of genes including MCM3 were shown to be differentially expressed which were specific to this kind of variant. Using immunohistochemistry method, MCM3 protein expression levels were compared in FVPTC, classic variant of papillary thyroid carcinoma (CVPTC), and multi-nodular goiter (MNG) tissues in a group of 32 cases. There was meaningful differences between MNG vs. FVPTC (p = 0.016) and MNG vs. CVPTC (p = 0.019) while there was no significant difference in the comparison FVPTC vs. CVPTC (p = 0.15). Four of the 5 CVPTC cases having surrounding tissue invasion had high expression values. For FVPTC and CVPTC, MCM3 protein expression results were parallel to our previous mRNA expression study while there was downregulation in protein expression despite the increased expression of MCM3 mRNA in MNG suggesting tissue-specific post-transcriptional events in benign thyroid neoplasms of which should be focused on. Moreover, the relatively lower MCM3 protein expression in FVPTC comparing to CVPTC could be due to a different tumorigenic pathway favored in this type of tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821456     DOI: 10.1007/s12253-013-9662-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

Review 1.  MCM proteins in DNA replication.

Authors:  B K Tye
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Cancer stem cell hypothesis in thyroid cancer.

Authors:  Ping Zhang; Hui Zuo; Takashi Ozaki; Nami Nakagomi; Kennichi Kakudo
Journal:  Pathol Int       Date:  2006-09       Impact factor: 2.534

3.  The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells.

Authors:  M A Madine; M Swietlik; C Pelizon; P Romanowski; A D Mills; R A Laskey
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 5.  Papillary thyroid carcinoma: an update.

Authors:  Virginia A LiVolsi
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

6.  Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

Authors:  Jeffrey Liu; Bhuvanesh Singh; Giovanni Tallini; Diane L Carlson; Nora Katabi; Ashok Shaha; R Michael Tuttle; Ronald A Ghossein
Journal:  Cancer       Date:  2006-09-15       Impact factor: 6.860

7.  Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.

Authors:  Seon-Ah Ha; Seung Min Shin; Hong Namkoong; Heejeong Lee; Goang Won Cho; Soo Young Hur; Tae Eung Kim; Jin Woo Kim
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

Review 8.  The MCM complex: its role in DNA replication and implications for cancer therapy.

Authors:  Ming Lei
Journal:  Curr Cancer Drug Targets       Date:  2005-08       Impact factor: 3.428

9.  Mutants of S. cerevisiae defective in the maintenance of minichromosomes.

Authors:  G T Maine; P Sinha; B K Tye
Journal:  Genetics       Date:  1984-03       Impact factor: 4.562

Review 10.  MCM proteins as diagnostic and prognostic tumor markers in the clinical setting.

Authors:  Constantinos Giaginis; Stephanie Vgenopoulou; Philippe Vielh; Stamatios Theocharis
Journal:  Histol Histopathol       Date:  2010-03       Impact factor: 2.303

View more
  4 in total

1.  Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis.

Authors:  Jing Yang; Yanping Gong; Shuping Yan; Qingquan Shi; Jingqiang Zhu; Zhihui Li; Qiang Chen; Rixiang Gong
Journal:  Mol Clin Oncol       Date:  2015-04-06

2.  Whole-transcriptome analysis of hepatocellular carcinoma.

Authors:  Lianjie Lin; Dongxu Wang; Nan Cao; Yan Lin; Yu Jin; Changqing Zheng
Journal:  Med Oncol       Date:  2013-10-18       Impact factor: 3.064

Review 3.  The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy.

Authors:  Yeon-Soo Seo; Young-Hoon Kang
Journal:  Front Mol Biosci       Date:  2018-03-29

4.  The role of septin 7 in physiology and pathological disease: A systematic review of current status.

Authors:  Xinlu Wang; Fei Fei; Jie Qu; Chunyuan Li; Yuwei Li; Shiwu Zhang
Journal:  J Cell Mol Med       Date:  2018-03-30       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.